UBS OCONNOR LLC - KITE PHARMA INC ownership

Quarter-by-quarter ownership
UBS OCONNOR LLC ownership history of KITE PHARMA INC
ValueSharesWeighting
Q3 2017$60,084,000,000
+24324.4%
334,153
+8253.8%
0.87%
+21725.0%
Q4 2015$246,000,000
-76.9%
4,000
-78.3%
0.00%
-77.8%
Q4 2014$1,064,000,00018,4450.02%
Other shareholders
KITE PHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Wildcat Capital Management, LLC 2,358,084$105,736,00048.63%
BAINCO INTERNATIONAL INVESTORS 1,151,540$51,635,0008.76%
Coastal Bridge Advisors, LLC 250,040$11,212,0004.36%
NEXTHERA CAPITAL LP 150,000$6,726,0003.94%
Casdin Capital, LLC 94,000$4,215,0003.48%
MENORA MIVTACHIM HOLDINGS LTD. 1,258,899$56,449,0002.90%
DIALECTIC CAPITAL MANAGEMENT, LP 85,000$3,812,0002.14%
SECTORAL ASSET MANAGEMENT INC 372,223$16,690,0001.85%
ARK Investment Management 97,313$4,364,0001.59%
BB BIOTECH AG 800,000$35,872,0001.33%
View complete list of KITE PHARMA INC shareholders